Clinical Trial Update: Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing exemestane versus anastrozole in postmenopausal women after surgery for primary breast cancer; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Exemestane (Exemestane)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-05-15